{"id":609,"date":"2020-12-21T13:37:46","date_gmt":"2020-12-21T13:37:46","guid":{"rendered":"https:\/\/ubimedical.pt\/?post_type=member&#038;p=609"},"modified":"2021-08-02T09:52:55","modified_gmt":"2021-08-02T09:52:55","slug":"c2icb-coordinating-center-of-clinical-research-of-beiras","status":"publish","type":"member","link":"https:\/\/ubimedical.pt\/pt\/startups\/c2icb-coordinating-center-of-clinical-research-of-beiras\/","title":{"rendered":"C2ICB \u2013 Centro Coordenador da Investiga\u00e7\u00e3o Cl\u00ednica das Beiras"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><div class=\"vc_row wpb_row row top-row wpb_custom_034b39d9bc6c6b310d69e39f0ccf274f\"><div class=\"vc_column_container col-md-4 vc_custom_1602778075739\"><div class=\"wpb_wrapper vc_column-inner\"><div class=\"porto-ultimate-content-box-container p-3 box-shadow-1 mb-4\"><style>.porto_ucb_21b6bf01188be9ba0119a2cb5c097588{will-change: box-shadow;box-shadow: none;}.porto_ucb_21b6bf01188be9ba0119a2cb5c097588:hover{box-shadow:none}<\/style><div class=\"porto-ultimate-content-box porto_ucb_21b6bf01188be9ba0119a2cb5c097588\" style=\"\">\r\n\t<div class=\"wpb_single_image wpb_content_element vc_align_center wpb_content_element  vc_custom_1608558407839  mb-4 wpb_custom_81a4f7ef9830bf958462581aa01150fb\"><div class=\"wpb_wrapper\">\r\n\t\t\t\r\n\t\t\t<div class=\"vc_single_image-wrapper   vc_box_border_grey\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/ubimedical.pt\/wp-content\/uploads\/2020\/12\/C2iCB_1.jpg\" class=\"vc_single_image-img attachment-full\" alt=\"\" title=\"C2iCB_1\" \/><\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><h3 style=\"font-size: 1.8em;line-height: 1\" class=\"vc_custom_heading vc_do_custom_heading mb-2 wpb_custom_aa365bd5046e8294520b4e73732b9d15 align-left\" >Director<\/h3><p  class=\"vc_custom_heading vc_do_custom_heading pb-3 wpb_custom_aa365bd5046e8294520b4e73732b9d15 align-left\" >Miguel Castelo-Branco<\/p><div class=\"porto-sicon-box mb-4  wpb_custom_1efe903570d178ff0a9b7bfa5febd3a4 style_1 default-icon\"><div class=\"porto-sicon-default\"><div class=\"porto-just-icon-wrapper porto-icon none\" style=\"color:#3467ef;font-size:27px;\"><i class=\"far fa-envelope\"><\/i><\/div><\/div><div class=\"porto-sicon-header\"><h5 class=\"porto-sicon-title\" style=\"line-height:1.2;\">E-MAIL<\/h5><p style=\"line-height:1.4;color:#3467ef;\">mcbranco@ubi.pt<\/p><\/div> <!-- header --><\/div><!-- porto-sicon-box --><\/div><\/div><div class=\"vc_column_container col-md-8\"><div class=\"wpb_wrapper vc_column-inner\"><p  class=\"vc_custom_heading vc_do_custom_heading mb-4 wpb_custom_aa365bd5046e8294520b4e73732b9d15 align-left\" >A miss\u00e3o do C2ICB consiste em suportar o desenvolvimento de produtos farmac\u00eauticos, dispositivos m\u00e9dicos e aspetos organizacionais promovendo uma variedade de servi\u00e7os inovadores a institui\u00e7\u00f5es e empresas cujo foco \u00e9 desenvolver e transferir os seus projetos para a pr\u00e1tica cl\u00ednica.<\/p><p  class=\"vc_custom_heading vc_do_custom_heading mb-4 wpb_custom_aa365bd5046e8294520b4e73732b9d15 align-left\" >O C2ICB est\u00e1 apto para coordenar os projetos de investiga\u00e7\u00e3o, fazer a gest\u00e3o, o processamento e o acompanhamento dos ensaios a decorrer, envolvendo:<\/p><div class=\"vc_row wpb_row vc_inner row\"><div class=\"mb-4 vc_column_container col-md-12\"><div class=\"wpb_wrapper vc_column-inner\"><div class=\"porto-sicon-box mb-2  wpb_custom_1efe903570d178ff0a9b7bfa5febd3a4 style_1 default-icon\"><div class=\"porto-sicon-default\"><div class=\"porto-just-icon-wrapper porto-icon advanced\" style=\"color:#222529;border-style:solid;border-color:#e7e7e7;border-width:1px;width:38px;height:38px;line-height:38px;border-radius:20px;font-size:11.2px;\"><i class=\"fas fa-check\"><\/i><\/div><\/div><div class=\"porto-sicon-header\"><h5 class=\"porto-sicon-title\" style=\"letter-spacing:0;\">O apoio ao promotor do projeto na defini\u00e7\u00e3o do perfil alvo do produto e no desenvolvimento do plano pr\u00e9-cl\u00ednico e regulamentar;<\/h5><\/div> <!-- header --><\/div><!-- porto-sicon-box --><div class=\"porto-sicon-box mb-2  wpb_custom_1efe903570d178ff0a9b7bfa5febd3a4 style_1 default-icon flex-wrap\"><div class=\"porto-sicon-default\"><div class=\"porto-just-icon-wrapper porto-icon advanced\" style=\"color:#222529;border-style:solid;border-color:#e7e7e7;border-width:1px;width:38px;height:38px;line-height:38px;border-radius:20px;font-size:11.2px;\"><i class=\"fas fa-check\"><\/i><\/div><\/div><div class=\"porto-sicon-header\"><h5 class=\"porto-sicon-title\" style=\"letter-spacing:0;\">A realiza\u00e7\u00e3o do servi\u00e7o completo, que vai desde o desenvolvimento do protocolo de ensaio cl\u00ednico at\u00e9 \u00e0 elabora\u00e7\u00e3o do relat\u00f3rio final:<\/h5><\/div> <!-- header --><div class=\"porto-sicon-description\" style=\"\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Organiza\u00e7\u00e3o dos pedidos de aconselhamento cient\u00edfico e regulamentar pelas autoridades competentes (INFARMED, FDA, EMA, etc), no caso de serem necess\u00e1rios.<\/li>\n<li>Prepara\u00e7\u00e3o do processo de pedido de aprova\u00e7\u00e3o do ensaio pelo INFARMED, CEIC e CNPD.<\/li>\n<li>Condu\u00e7\u00e3o da parte cl\u00ednica, de acordo com os melhores padr\u00f5es \u00e9ticos e de Boa Pr\u00e1tica Cl\u00ednica.<\/li>\n<li>Gest\u00e3o de dados de acordo com os requisitos regulamentares mais exigentes.<\/li>\n<li>Possibilidade de fazer uso de software goldstandard na an\u00e1lise (SAS, Stata, SPSS, etc.) e organiza\u00e7\u00e3o dos dados segundo o CDISC.<\/li>\n<li>Aconselhamento epidemiol\u00f3gico incluindo sobre dimens\u00e3o de amostras.<\/li>\n<li>Relat\u00f3rio final de ensaio cl\u00ednico pronto a submeter \u00e0s autoridades regulamentares internacionais mais exigentes.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><\/div> <!-- description --><\/div><!-- porto-sicon-box --><div class=\"porto-sicon-box mb-2  wpb_custom_1efe903570d178ff0a9b7bfa5febd3a4 style_1 default-icon\"><div class=\"porto-sicon-default\"><div class=\"porto-just-icon-wrapper porto-icon advanced\" style=\"color:#222529;border-style:solid;border-color:#e7e7e7;border-width:1px;width:38px;height:38px;line-height:38px;border-radius:20px;font-size:11.2px;\"><i class=\"fas fa-check\"><\/i><\/div><\/div><div class=\"porto-sicon-header\"><h5 class=\"porto-sicon-title\" style=\"letter-spacing:0;\">Os apoios \u00e0 investiga\u00e7\u00e3o, designadamente: estat\u00edstica, tradu\u00e7\u00e3o, divulga\u00e7\u00e3o, forma\u00e7\u00e3o, jur\u00eddico e de gest\u00e3o.<\/h5><\/div> <!-- header --><\/div><!-- porto-sicon-box --><div class=\"porto-sicon-box mb-2  wpb_custom_1efe903570d178ff0a9b7bfa5febd3a4 style_1 default-icon\"><div class=\"porto-sicon-default\"><div class=\"porto-just-icon-wrapper porto-icon advanced\" style=\"color:#222529;border-style:solid;border-color:#e7e7e7;border-width:1px;width:38px;height:38px;line-height:38px;border-radius:20px;font-size:11.2px;\"><i class=\"fas fa-check\"><\/i><\/div><\/div><div class=\"porto-sicon-header\"><h5 class=\"porto-sicon-title\" style=\"letter-spacing:0;\">O fomento de parcerias com outros hospitais e unidades de cuidados de sa\u00fade prim\u00e1rios portugueses e cuidados continuados e paliativos, para ter acesso aos pacientes alvo dos ensaios a realizar, bem como com entidades internacionais.<\/h5><\/div> <!-- header --><\/div><!-- porto-sicon-box --><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"Director:Miguel Castelo-BrancoE-MAILmcbranco@ubi.pt The mission of C2ICB consists of supporting the development of pharmaceuticals, medical devices and organizational aspects by providing a variety of innovative services to institutions and companies whose focus is developing and transferring their projects to the clinical practice.C2ICB is prepared to coordinate research projects, management, processing and follow-up on ongoing trials involving:Support [...]","protected":false},"featured_media":612,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","member_cat":[12],"class_list":["post-609","member","type-member","status-publish","has-post-thumbnail","hentry","member_cat-labs"],"_links":{"self":[{"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/member\/609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/member"}],"about":[{"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/types\/member"}],"replies":[{"embeddable":true,"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/comments?post=609"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/media\/612"}],"wp:attachment":[{"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/media?parent=609"}],"wp:term":[{"taxonomy":"member_cat","embeddable":true,"href":"https:\/\/ubimedical.pt\/pt\/wp-json\/wp\/v2\/member_cat?post=609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}